4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-109397
Co-Chief Executive Officer acquired 1,857 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2024-09-23 | Option exercise | +1,857 | $1.57 | $2,915 | 3,239,158 | D |
| Derivatives | |||||||
| Cohen Joshua B Co-Chief Executive Officer | 2024-09-23 | Option exercise · Stock Option (right to buy) | −1,857 | 0 | D | ||
Loading xslF345X05/ownership.xml…